Literature DB >> 11792632

Bulk shear viscosities of endogenous and exogenous lung surfactants.

David M King1, Zhengdong Wang, Harvey J Palmer, Bruce A Holm, Robert H Notter.   

Abstract

Bulk shear viscosities were measured with a cone and plate microviscometer as a function of concentration, shear rate, and temperature for lavaged calf lung surfactant (LS), Exosurf, Infasurf, Survanta, and synthetic lipid mixtures dispersed in normal saline. Viscosity increased with phospholipid concentration for all surfactants, but its magnitude and shear dependence varied widely among the different preparations. Saline dispersions of Exosurf and synthetic phospholipids had low viscosities of only a few centipoise (cp) and exhibited minimal shear dependence. LS, Infasurf, Survanta, and lipid mixtures containing palmitic acid and tripalmitin had larger non-Newtonian viscosities that increased as shear rate decreased. At 35 mg of phospholipid/ml and 37 degrees C, viscosity values were 52.3 cp (Survanta), 31.1 cp (LS), and 25 cp (Infasurf) at a shear rate of 77 s(-1) and 16.9 cp (Survanta), 10.1 cp (LS), and 6.6 cp (Infasurf) at 770 s(-1). At 25 mg of phospholipid/ml and 37 degrees C, viscosity values at 77 s(-1) were 28.8 cp (Survanta), 4.7 cp (LS), and 12.5 cp (Infasurf). At fixed shear rate, viscosity was substantially decreased at 23 degrees C compared with 37 degrees C for LS and Infasurf but was increased for Survanta. Calcium (5 mM) greatly reduced the viscosity of both Survanta and Infasurf at 37 degrees C. Studies on synthetic mixtures indicated that phospholipid/apoprotein interactions were important in the rheology of lung-derived surfactants and that palmitic acid and tripalmitin contributed to the increased viscosity of Survanta. The viscous behavior of clinical exogenous surfactants potentially influences their delivery and distribution in lungs and varies significantly with composition, concentration, temperature, ionic environment, and physical formulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792632     DOI: 10.1152/ajplung.00199.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

1.  Three-dimensional model of surfactant replacement therapy.

Authors:  Marcel Filoche; Cheng-Feng Tai; James B Grotberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 2.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 3.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

4.  Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.

Authors:  Karen W Lu; Jesús Pérez-Gil; H William Taeusch
Journal:  Biochim Biophys Acta       Date:  2009-03

5.  Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.

Authors:  Robert H Notter; Rohun Gupta; Adrian L Schwan; Zhengdong Wang; Mohanad Gh Shkoor; Frans J Walther
Journal:  PeerJ       Date:  2016-10-27       Impact factor: 2.984

Review 6.  Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.

Authors:  Federico Bianco; Fabrizio Salomone; Ilaria Milesi; Xabier Murgia; Sauro Bonelli; Elena Pasini; Raffaele Dellacà; Maria Luisa Ventura; Jane Pillow
Journal:  Respir Res       Date:  2021-02-26

7.  Surfactant delivery in rat lungs: Comparing 3D geometrical simulation model with experimental instillation.

Authors:  Alireza Kazemi; Bruno Louis; Daniel Isabey; Gary F Nieman; Louis A Gatto; Joshua Satalin; Sarah Baker; James B Grotberg; Marcel Filoche
Journal:  PLoS Comput Biol       Date:  2019-10-17       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.